Results 181 to 190 of about 43,190 (248)

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

New England Journal of Medicine, 2017
J. Weitz, A. Lensing, M. Prins, R. Bauersachs, J. Beyer-Westendorf, H. Bounameaux, T. Brighton, A. Cohen, B. Davidson, H. Décousus, M. S. Freitas, G. Holberg, Ajay Kakkar, L. Haskell, B. van Bellen, Á. Pap, S. Berkowitz, P. Verhamme, P. Wells, P. Prandoni   +19 more
semanticscholar   +1 more source

Potential role of rivaroxaban in patients with acute coronary syndrome

, 2012
David Fitchett
openalex   +2 more sources

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) [PDF]

, 2014
Jonathan L. Halperin, Graeme J. Hankey, Daniel Wojdyla, Jonathan P. Piccini, Yuliya Lokhnygina, Manesh R. Patel, Günter Breithardt, Daniel E. Singer, Richard C. Becker, Werner Hacke, John F. Paolini, Christopher C. Nessel, Kenneth W. Mahaffey, Robert M. Califf, Keith A.A. Fox   +14 more
openalex   +1 more source

Editor's Choice - Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials [PDF]

, 2014
Stavros K. Kakkos, George Kirkilesis, Ioannis A. Tsolakis   +2 more
openalex   +1 more source

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry [PDF]

, 2014
Jan Beyer‐Westendorf, Kati Förster, Sven Pannach, Franziska Ebertz, Vera Gelbricht, Christoph Thieme, Franziska Michalski, Christina Köhler, Sebastian Werth, Kurtuluş Şahin, Luise Tittl, Ulrike Hänsel, Norbert Weiss   +12 more
openalex   +1 more source

Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro [PDF]

, 2014
Elisabeth Perzborn, Stefan Heitmeier, Volker Laux, Anja Buchmüller   +3 more
openalex   +1 more source

Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban

, 2013
Louis M. Kwong
openalex   +2 more sources

XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis [PDF]

, 2014
Walter Ageno, LG Mantovani, Sylvia Haas, Reinhold Kreutz, Verena Haupt, Jonas Schneider, Alexander GG Turpie   +6 more
openalex   +1 more source

Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs [PDF]

, 2014
Raúl Altman, Claudio González
openalex   +1 more source

Venous Thromboembolism Due to Suspected Interaction Between Nevirapine and Rivaroxaban

, 2013
Duane Bates, Bruce Dalton, Janet Gilmour, Jeff Kapler   +3 more
openalex   +2 more sources